Onkure Therapeutics Inc. Class AOKUR
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 47 institutions reported holding Onkure Therapeutics Inc. Class A (OKUR) in their 13F filings, down 4 from Q4 2024. 4 opened new positions and 8 sold out. The largest holders were Cormorant Asset Management, LP ($7.9M), Acorn Capital Advisors, LLC ($5.1M) and Citadel Advisors ($4.4M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Onkure Therapeutics Inc. Class A
- CUSIP
- 68277Q105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $347K |
| Exits | 8 | $4.0M |
All 13F filers, Q4 2024 → Q1 2025: 855,355 shares bought and 749,436 shares sold, net +105,919 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Cormorant Asset Management, LP | 0.60% | No change | 1,837,739 | $7.9M |
| Acorn Capital Advisors, LLC | 3.42% | No change | 1,439,674 | $5.1M |
| Citadel Advisors | 0.00% | Reduce -0.6% | 1,068,104 | $4.4M |
| Perceptive Advisors LLC | 0.15% | No change | 1,004,439 | $4.3M |
| Samsara Biocapital, LLC | 0.63% | No change | 824,155 | $3.5M |
| Vanguard Group Inc. | 0.00% | No change | 706,733 | $3.0M |
| Vestal Point Capital, LP | 0.20% | No change | 635,000 | $2.7M |
| Deep Track Capital, LP | 0.07% | No change | 523,989 | $2.3M |
| StepStone Group LP | 2.17% | No change | 491,938 | $2.1M |
| NEA Management Company, LLC | 0.16% | No change | 478,548 | $2.1M |
| Highbridge Capital Management LLC | 0.30% | Add +9.8% | 438,797 | $1.9M |
| Tang Capital Management LLC | 0.10% | Add +35.8% | 400,000 | $1.7M |
| Affinity Asset Advisors, LLC | 0.28% | Add +173.4% | 394,159 | $1.7M |
| Carlyle Group Inc. | 0.03% | No change | 269,895 | $1.2M |
| Ikarian Capital, LLC | 0.36% | No change | 253,754 | $1.1M |
| Prosight Management, LP | 0.26% | Add +192.6% | 186,570 | $802K |
| Shay Capital LLC | 0.19% | Add +905.9% | 151,038 | $649K |
| Cantor Fitzgerald, L. P. | 0.02% | Add +266.1% | 130,700 | $562K |
| BlackRock, Inc. | 0.00% | Reduce -5.4% | 88,981 | $383K |
| Aisling Capital Management LP | 0.13% | No change | 88,607 | $381K |
| Geode Capital Management, LLC | 0.00% | Add +12.7% | 86,311 | $371K |
| Sphera Funds Management LTD. | 0.09% | Reduce -7.9% | 80,454 | $346K |
| Boothbay Fund Management, LLC | 0.01% | No change | 78,021 | $335K |
| Nantahala Capital Management, LLC | 0.02% | Reduce -1.0% | 54,208 | $233K |
| Aldebaran Capital, LLC | 0.18% | Reduce -1.1% | 45,048 | $194K |
| Renaissance Technologies | 0.00% | Reduce -11.8% | 41,863 | $180K |
| Two Sigma Advisers, LP | 0.00% | Add +94.2% | 27,628 | $119K |
| Two Sigma Investments, LP | 0.00% | New | 27,148 | $117K |
| Bridgeway Capital Management, LLC | 0.00% | New | 25,000 | $108K |
| Northern Trust Corp. | 0.00% | No change | 19,177 | $82K |
| Qube Research & Technologies Ltd | 0.00% | New | 18,663 | $80K |
| ADAR1 Capital Management, LLC | 0.01% | New | 10,000 | $43K |
| Barclays PLC | 0.00% | Reduce -22.6% | 6,765 | $29K |
| Wells Fargo & Company | 0.00% | Add +123.5% | 3,620 | $16K |
| China Universal Asset Management Co., Ltd. | 0.00% | Reduce -5.4% | 2,538 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1.0% | 2,224 | $10K |
| Morgan Stanley | 0.00% | Add +101.5% | 1,878 | $8K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +0.2% | 423 | $2K |
| GF Fund Management Co. LTD. | 0.00% | Add +17.7% | 313 | $1K |
| BNP Paribas Financial Markets | 0.00% | Add +25.9% | 297 | $1K |
| UBS Group AG | 0.00% | Reduce -87.3% | 280 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -31.4% | 231 | $993 |
| Bank of America Corp. | 0.00% | Reduce -99.9% | 221 | $950 |
| Citigroup Inc. | 0.00% | Add +86.3% | 190 | $818 |
| Group One Trading LLC | 0.00% | Reduce -80.6% | 56 | $241 |
| MAI Capital Management | 0.00% | No change | 6 | $26 |
| Royal Bank of Canada | 0.00% | Reduce -25.6% | 32 | $0 |
"% of holder's portfolio" is OKUR's weight in each manager's 13F, not the share of Onkure Therapeutics Inc. Class A the manager owns.